Share
To invite people, share this page:
About
This interactive discussion featured Harry Glorikian, author of MoneyBall Medicine joined by Ülo Palm, Thomas Bock, and Lixia Wang discussing their current work and future outlook along with the important work that The APANDEMIC Initiative has set out to do.
Price
Free
Language
English
Who can attend
Everyone
Dial-in available? (listen only)
Not available.
Agenda
  • The definition of RWE
  • Examples of companies that are effectively working with biopharma to ensure that RWD is thoughtfully collected and analyzed to turn it into a powerful tool
  • The ability of RWE to predict future pandemics
  • Challenges to adoption
  • Privacy concerns
  • The potential over reliance on p-values
  • RCT’s (random clinical trials) limitations on drug efficacy in big populations
  • Working with regulators

Hosted By AI in Biopharma

Featured Presenters
Conversation